Perceptive Advisors

Last updated

Perceptive Advisors LLC
Company type Private
Industry Investment management
FoundedJuly 1999;25 years ago (1999-07)
Founder Joseph Edelman
Headquarters 51 Astor Place, New York City, New York, U.S.
Key people
Joseph Edelman (CEO)
Products Hedge fund
Venture capital
Private equity
Private credit
AUM US$9.7 billion (March 2024)
Number of employees
46 (March 2024)
Website www.perceptivelife.com
Footnotes /references
[1]

Perceptive Advisors ("Perceptive") is an American investment firm headquartered in New York City. It is focused on making public and private investments in the healthcare and biotechnology industries.

Contents

Background

Perceptive Advisors was founded in July 1999 by Joseph Edelman. Edelman was previously a senior analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund as well as a senior bBiotechnology analyst at Prudential Securities. His father was Isidore Edelman, a physician and researcher who became chair of the biochemistry and molecular biophysics department at Columbia University. [2] [3] [4]

The firm's flagship fund is called the Perceptive Life Sciences Fund. The firm takes a high risk approach to investing as the biotech sector is considered very volatile and it take years to develop a drug that could be rejected by the Food and Drug Administration. The firm tends to focus on small and midcap companies and it may overpay for securities if it there is still growth potential or undersell securities if they have further downside potential. To help mitigate day-to-day volatility, it has set a maximum daily loss allowance of five percent on long and short positions. [2]

In 2013, Perceptive launched its first credit fund, Perceptive Credit Opportunities Fund which raised $323 million. It would invest in vehicles such as direct secured loans, royalties and convertible structures for public and private companies. [2] [4]

In August 2018, Institutional Investor stated that Perceptive since inception only had two years of negative returns. It had lost 10.33% in 2002 and 23.98% in 2008. [2]

In December 2019, Perceptive partnered with Xontogeny, a biotech startup accelerator to launch its first venture capital fund, Perceptive Xontogeny Venture Fund which raised $210 million. The fund would invest in biotech companies that were in preclinical development stage and help them move into the early clinical development stages. Prior to that Perceptive invested mainly in later-stage companies. [2] [5] [6]

At the end of 2022, it was reported that Perceptive posted losses of more than 40% during the last two years. These were considered the worst losses in the firm's history. [7] [8] [9]

SEC SPAC fine

In September 2022, the U.S. Securities and Exchange Commission sued Perceptive for failing to disclose conflicts of interest related to special-purpose acquisition companies (SPACs). It claimed that in 2020, Perceptive advised its clients to invest in a series of SPACs without disclosing they were owned by both the firm's personnel and a private fund it had advised. Perceptive agreed to pay a $1.5 million fine to settle the case. [10] [11] [12]

Related Research Articles

A hedge fund is a pooled investment fund that holds liquid assets and that makes use of complex trading and risk management techniques to improve investment performance and insulate returns from market risk. Among these portfolio techniques are short selling and the use of leverage and derivative instruments. In the United States, financial regulations require that hedge funds be marketed only to institutional investors and high-net-worth individuals.

Private equity (PE) is capital stock in a private company that does not offer stock to the general public. In the field of finance, private equity is offered instead to specialized investment funds and limited partnerships that take an active role in the management and structuring of the companies. In casual usage, "private equity" can refer to these investment firms rather than the companies that they invest in.

The Investment Company Act of 1940 is an act of Congress which regulates investment funds. It was passed as a United States Public Law on August 22, 1940, and is codified at 15 U.S.C. §§ 80a-1–80a-64. Along with the Securities Exchange Act of 1934, the Investment Advisers Act of 1940, and extensive rules issued by the U.S. Securities and Exchange Commission; it is central to financial regulation in the United States. It has been updated by the Dodd-Frank Act of 2010. It is the primary source of regulation for mutual funds and closed-end funds, now a multi-trillion dollar investment industry. The 1940 Act also impacts the operations of hedge funds, private equity funds and even holding companies.

A special-purpose acquisition company, also known as a "blank check company", is a shell corporation listed on a stock exchange with the purpose of acquiring a private company, thus making the private company public without going through the initial public offering process, which often carries significant procedural and regulatory burdens. According to the U.S. Securities and Exchange Commission (SEC), SPACs are created specifically to pool funds to finance a future merger or acquisition opportunity within a set timeframe; these opportunities usually have yet to be identified while raising funds.

Amaranth Advisors LLC was an American multi-strategy hedge fund founded by Nicholas M. Maounis and headquartered in Greenwich, Connecticut. At its peak, the firm had up to $9.2 billion in assets under management before collapsing in September 2006, after losing in excess of $6 billion on natural gas futures. Amaranth Advisors collapse is one of the biggest hedge fund collapses in history and at the time (2006) largest known trading losses.

Khosla Ventures is a private American venture capital firm based in Menlo Park, California. It was founded by entrepreneur Vinod Khosla in 2004. The firm focused on early-stage companies in the Internet, computing, mobile, financial services, agriculture, healthcare and clean technology sectors. Some of its most successful investments include Affirm, DoorDash, Square, Impossible Foods, Instacart, and OpenAI.

Elliott Investment Management L.P. is an American investment management firm. It is also one of the largest activist funds in the world.

<span class="mw-page-title-main">Pershing Square Capital Management</span> American hedge fund

Pershing Square Capital Management is an American hedge fund management company founded and run by Bill Ackman, headquartered in New York City.

<span class="mw-page-title-main">Chamath Palihapitiya</span> Sri Lankan-born businessman

Chamath Palihapitiya is a Sri Lankan-born Canadian and American venture capitalist, engineer, SPAC sponsor, founder and CEO of Social Capital. Palihapitiya was an early senior executive at Facebook, working at the company from 2007 to 2011. Following his departure from Facebook, Palihapitiya started The Social+Capital Partnership, through which he invested in several companies, including Yammer and Slack. He is a co-host of a technology podcast, All-In, along with David Sacks, Jason Calacanis, and David Friedberg.

Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013, and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.

Saba Capital Management (Saba) is a credit relative value focused hedge fund firm established in 2009. It also has strategies in tail hedge, closed-end funds and SPACs.

Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Joseph Edelman is an American hedge fund manager who founded Perceptive Advisors, a New York City-based hedge fund specializing in the healthcare sector and biotechnology. He helped take biotech firms public via the use of special-purpose acquisition companies.

<span class="mw-page-title-main">Tiger Global Management</span> American investment firm

Tiger Global Management, LLC is an American investment firm founded by Chase Coleman III, a former Tiger Management employee under Julian Robertson, in March 2001. It mainly focuses on internet, software, consumer, and financial technology companies.

OrbiMed is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered one of the world's largest dedicated healthcare investment firms.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Trump Media & Technology Group Corp. (TMTG) is an American media and technology company headquartered in Sarasota, Florida. It is best known as the owner of Truth Social and for being primarily owned by former U.S. president Donald Trump. It also plans to launch a subscription based streaming service called TMTG+. Founded by Andy Litinsky and Wes Moss in 2021, it went public on March 26, 2024, after merging with Digital World Acquisition Corp. (DWAC), a special-purpose acquisition company (SPAC).

RA Capital Management is an American investment firm based in Boston. It is focused on making public and private investments in the Healthcare and Biotechnology industries.

<span class="mw-page-title-main">Hudson Bay Capital Management</span> American Hedge Fund

Hudson Bay CapitalManagement (HBC) is an American multi-strategy investment management firm headquartered in Greenwich, Connecticut.

References

  1. ↑ "Form ADV" (PDF). SEC.
  2. 1 2 3 4 5 "The 41% Man". Institutional Investor. August 13, 2018. Retrieved April 11, 2023.
  3. ↑ Roche, Julia La. "This hedge fund crushed the competition in 2015". Business Insider. Retrieved April 11, 2023.
  4. 1 2 Lawrence, Stacy (October 25, 2016). "Hedge fund Perceptive raises $323M life sciences debt fund". Fierce Biotech.
  5. ↑ "Hedge Fund Firm Perceptive Advisors Raises First VC Fund". Institutional Investor. December 10, 2019. Retrieved April 11, 2023.
  6. ↑ Al Idrus, Amirah (May 12, 2021). "Perceptive Advisors unveils $515M fund, its 2nd for early-stage biotechs". Fierce Biotech.
  7. ↑ Chung, Gregory Zuckerman and Juliet (December 5, 2021). "WSJ News Exclusive | Hedge Funds Suffer Big Losses on Biotech Rout". Wall Street Journal. Retrieved April 12, 2023.
  8. ↑ "Stock Hedge Funds Erase Billions With Another Year of Losses". Bloomberg.com. December 28, 2022. Retrieved April 11, 2023.
  9. ↑ "Perceptive Posts Biggest Loss in Its History". Institutional Investor. January 14, 2022. Retrieved April 11, 2023.
  10. ↑ "SEC Sues SPAC Adviser for Not Disclosing Conflicts of Interest". Bloomberg.com. September 6, 2022. Retrieved April 11, 2023.
  11. ↑ "SEC Charges Perceptive Advisors". Institutional Investor. September 6, 2022. Retrieved April 11, 2023.
  12. ↑ "Perceptive Advisors to pay $1.5m to settle SEC charges relating to SPAC conflicts of interest". Hedgeweek. September 7, 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.